{"transactions":[{"id":4614393,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-10T13:22:53.000Z","date":"2026-09-08","kind":"exercise","planned":true,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares vested on July 4, 2020, and the remaining shares vested in 36 equal monthly installments thereafter."}],"balance_after":78987,"derivative":{"exercise_price":4.3,"expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001193125-26-387381","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1838061/000119312526387381/ownership.xml","form_type":"4"}},{"id":4614392,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-09-10T13:22:53.000Z","date":"2026-09-08","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":21.57,"value":172560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.31  to $21.83. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":158844,"source":{"system":"sec-edgar","filing":"0001193125-26-387381","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1838061/000119312526387381/ownership.xml","form_type":"4"}},{"id":4614391,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-09-10T13:22:53.000Z","date":"2026-09-08","kind":"exercise","planned":true,"acquired":true,"shares":4000,"price":4.3,"value":17200.0,"ownership":{"direct":true},"balance_after":166844,"source":{"system":"sec-edgar","filing":"0001193125-26-387381","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1838061/000119312526387381/ownership.xml","form_type":"4"}},{"id":686431,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-14T21:00:06.000Z","date":"2026-08-13","kind":"exercise","planned":true,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares vested on July 4, 2020, and the remaining shares vested in 36 equal monthly installments thereafter."}],"balance_after":82987,"derivative":{"exercise_price":4.3,"expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001193125-26-352523","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526352523/ownership.xml","form_type":"4"}},{"id":686430,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-08-14T21:00:06.000Z","date":"2026-08-13","kind":"sale","planned":true,"acquired":false,"shares":30000,"price":20.26,"value":607800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.69. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":162844,"source":{"system":"sec-edgar","filing":"0001193125-26-352523","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526352523/ownership.xml","form_type":"4"}},{"id":686429,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-08-14T21:00:06.000Z","date":"2026-08-13","kind":"exercise","planned":true,"acquired":true,"shares":30000,"price":4.3,"value":129000.0,"ownership":{"direct":true},"balance_after":192844,"source":{"system":"sec-edgar","filing":"0001193125-26-352523","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526352523/ownership.xml","form_type":"4"}},{"id":713332,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-07T21:00:09.000Z","date":"2026-07-06","kind":"exercise","planned":true,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares vested on July 4, 2020, and the remaining shares vested in 36 equal monthly installments thereafter."}],"balance_after":112987,"derivative":{"exercise_price":4.3,"expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001193125-26-297605","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526297605/ownership.xml","form_type":"4"}},{"id":713331,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-07-07T21:00:09.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":17.82,"value":142560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.35 to $18.19. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":162844,"source":{"system":"sec-edgar","filing":"0001193125-26-297605","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526297605/ownership.xml","form_type":"4"}},{"id":713330,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-07-07T21:00:09.000Z","date":"2026-07-06","kind":"exercise","planned":true,"acquired":true,"shares":4000,"price":4.3,"value":17200.0,"ownership":{"direct":true},"balance_after":170844,"source":{"system":"sec-edgar","filing":"0001193125-26-297605","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526297605/ownership.xml","form_type":"4"}},{"id":789421,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-06T21:00:27.000Z","date":"2026-05-05","kind":"exercise","planned":true,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares vested on July 4, 2020, and the remaining shares vested in 36 equal monthly installments thereafter."}],"balance_after":116987,"derivative":{"exercise_price":4.3,"expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001193125-26-209307","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526209307/ownership.xml","form_type":"4"}},{"id":789420,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-05-06T21:00:27.000Z","date":"2026-05-05","kind":"sale","planned":true,"acquired":false,"shares":200,"price":15.58,"value":3116.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.56 to $15.60. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":166844,"source":{"system":"sec-edgar","filing":"0001193125-26-209307","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526209307/ownership.xml","form_type":"4"}},{"id":789419,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-05-06T21:00:27.000Z","date":"2026-05-05","kind":"sale","planned":true,"acquired":false,"shares":7800,"price":14.6,"value":113880.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.24 to $15.12. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":167044,"source":{"system":"sec-edgar","filing":"0001193125-26-209307","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526209307/ownership.xml","form_type":"4"}},{"id":789418,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-05-06T21:00:27.000Z","date":"2026-05-05","kind":"exercise","planned":true,"acquired":true,"shares":4000,"price":4.3,"value":17200.0,"ownership":{"direct":true},"balance_after":174844,"source":{"system":"sec-edgar","filing":"0001193125-26-209307","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526209307/ownership.xml","form_type":"4"}},{"id":852915,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-09T21:00:03.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares vested on July 4, 2020, and the remaining shares vested in 36 equal monthly installments thereafter."}],"balance_after":120987,"derivative":{"exercise_price":4.3,"expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001193125-26-098781","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526098781/ownership.xml","form_type":"4"}},{"id":852914,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-09T21:00:03.000Z","date":"2026-03-05","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":15.68,"value":125440.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.38 to $16.31. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":170844,"source":{"system":"sec-edgar","filing":"0001193125-26-098781","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526098781/ownership.xml","form_type":"4"}},{"id":852913,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-09T21:00:03.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":true,"shares":4000,"price":4.3,"value":17200.0,"ownership":{"direct":true},"balance_after":178844,"source":{"system":"sec-edgar","filing":"0001193125-26-098781","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526098781/ownership.xml","form_type":"4"}},{"id":879207,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-26T22:05:13.000Z","date":"2026-02-25","kind":"sale","planned":true,"acquired":false,"shares":1780,"price":14.14,"value":25169.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.89 to $14.35. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":174844,"source":{"system":"sec-edgar","filing":"0001193125-26-077259","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526077259/ownership.xml","form_type":"4"}},{"id":881309,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-25T22:00:07.000Z","date":"2026-02-24","kind":"sale","planned":true,"acquired":false,"shares":3601,"price":14.47,"value":52106.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":176624,"source":{"system":"sec-edgar","filing":"0001193125-26-072002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526072002/ownership.xml","form_type":"4"}},{"id":881308,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-25T22:00:07.000Z","date":"2026-02-23","kind":"sale","planned":true,"acquired":false,"shares":1752,"price":13.99,"value":24510.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.68 to $14.31. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":180225,"source":{"system":"sec-edgar","filing":"0001193125-26-072002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526072002/ownership.xml","form_type":"4"}},{"id":887428,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-23T22:00:06.000Z","date":"2026-02-20","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares vested on July 4, 2020, and the remaining shares vested in 36 equal monthly installments thereafter."}],"balance_after":124987,"derivative":{"exercise_price":4.3,"expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001193125-26-064256","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526064256/ownership.xml","form_type":"4"}},{"id":887427,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-23T22:00:06.000Z","date":"2026-02-20","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":14.3,"value":114400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025."}],"balance_after":181977,"source":{"system":"sec-edgar","filing":"0001193125-26-064256","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526064256/ownership.xml","form_type":"4"}},{"id":887426,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-23T22:00:06.000Z","date":"2026-02-20","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":4.3,"value":34400.0,"ownership":{"direct":true},"balance_after":189977,"source":{"system":"sec-edgar","filing":"0001193125-26-064256","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526064256/ownership.xml","form_type":"4"}},{"id":887425,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-23T22:00:06.000Z","date":"2026-02-20","kind":"sale","planned":true,"acquired":false,"shares":3742,"price":13.62,"value":50966.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":181977,"source":{"system":"sec-edgar","filing":"0001193125-26-064256","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526064256/ownership.xml","form_type":"4"}},{"id":892411,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-19T22:00:03.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date."}],"balance_after":115000,"derivative":{"exercise_price":12.44,"expiration_date":"2036-02-18","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001193125-26-059636","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526059636/ownership.xml","form_type":"4"}},{"id":892410,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-19T22:00:03.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":57500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares underlying the restricted stock unit vest on an annual basis over four years."}],"balance_after":185719,"source":{"system":"sec-edgar","filing":"0001193125-26-059636","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526059636/ownership.xml","form_type":"4"}},{"id":904535,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-13T22:00:21.000Z","date":"2026-02-12","kind":"sale","planned":false,"acquired":false,"shares":416,"price":12.03,"value":5004.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":128219,"source":{"system":"sec-edgar","filing":"0001193125-26-051700","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526051700/ownership.xml","form_type":"4"}},{"id":931905,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-01-23T22:00:03.000Z","date":"2026-01-22","kind":"sale","planned":true,"acquired":false,"shares":4000,"price":12.3,"value":49200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025."}],"balance_after":128635,"source":{"system":"sec-edgar","filing":"0001193125-26-021225","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526021225/ownership.xml","form_type":"4"}},{"id":960588,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-22T22:00:10.000Z","date":"2025-12-19","kind":"sale","planned":true,"acquired":false,"shares":1345,"price":10.01,"value":13463.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.99 to $10.09. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":132635,"source":{"system":"sec-edgar","filing":"0001193125-25-328909","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312525328909/ownership.xml","form_type":"4"}},{"id":961719,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-19T22:00:09.000Z","date":"2025-12-18","kind":"sale","planned":false,"acquired":false,"shares":2898,"price":9.67,"value":28023.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":133980,"source":{"system":"sec-edgar","filing":"0001193125-25-327027","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312525327027/ownership.xml","form_type":"4"}},{"id":966969,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-16T22:00:13.000Z","date":"2025-12-15","kind":"sale","planned":true,"acquired":false,"shares":995,"price":11.9,"value":11840.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025."}],"balance_after":136878,"source":{"system":"sec-edgar","filing":"0001193125-25-321122","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312525321122/ownership.xml","form_type":"4"}},{"id":966968,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-16T22:00:13.000Z","date":"2025-12-12","kind":"sale","planned":true,"acquired":false,"shares":2148,"price":12.38,"value":26592.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,017 shares of common stock that the Reporting Person purchased pursuant to the Issuer's 2021 Employee Stock Purchase Plan for the purchase period of January 1, 2025 through June 30, 2025 that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":137873,"source":{"system":"sec-edgar","filing":"0001193125-25-321122","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312525321122/ownership.xml","form_type":"4"}},{"id":988305,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-11-25T22:00:03.000Z","date":"2025-11-24","kind":"sale","planned":true,"acquired":false,"shares":4000,"price":12.3,"value":49200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025."}],"balance_after":138004,"source":{"system":"sec-edgar","filing":"0001193125-25-297549","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312525297549/ownership.xml","form_type":"4"}},{"id":1240057,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-27T22:00:06.000Z","date":"2025-02-25","kind":"sale","planned":false,"acquired":false,"shares":3756,"price":8.53,"value":32038.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":142004,"source":{"system":"sec-edgar","filing":"0000950170-25-029200","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017025029200/ownership.xml","form_type":"4"}},{"id":1252103,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-21T23:00:10.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date."}],"balance_after":100000,"derivative":{"exercise_price":9.43,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000950170-25-025032","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017025025032/ownership.xml","form_type":"4"}},{"id":1252102,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-21T23:00:10.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares underlying the restricted stock unit vest on an annual basis over four years."}],"balance_after":145760,"source":{"system":"sec-edgar","filing":"0000950170-25-025032","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017025025032/ownership.xml","form_type":"4"}},{"id":1307433,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-01-07T22:00:04.000Z","date":"2025-01-06","kind":"sale","planned":true,"acquired":false,"shares":4000,"price":12.51,"value":50040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on January 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.32 to $12.62. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote."}],"balance_after":95760,"source":{"system":"sec-edgar","filing":"0000950170-25-002946","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017025002946/ownership.xml","form_type":"4"}},{"id":1323787,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-12-20T22:00:07.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":4693,"price":11.41,"value":53547.13,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":99760,"source":{"system":"sec-edgar","filing":"0000950170-24-139125","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017024139125/ownership.xml","form_type":"4"}},{"id":1330428,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-12-16T22:00:04.000Z","date":"2024-12-12","kind":"sale","planned":false,"acquired":false,"shares":3489,"price":12.52,"value":43682.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":104453,"source":{"system":"sec-edgar","filing":"0000950170-24-136726","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017024136726/ownership.xml","form_type":"4"}},{"id":1372545,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-11-07T22:30:04.000Z","date":"2024-11-05","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":15.64,"value":125120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on January 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.25 to $15.98. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":107942,"source":{"system":"sec-edgar","filing":"0000950170-24-123538","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017024123538/ownership.xml","form_type":"4"}},{"id":1411597,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-09-09T21:30:03.000Z","date":"2024-09-05","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":18.09,"value":144720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on January 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.79 to $18.55. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":115942,"source":{"system":"sec-edgar","filing":"0000950170-24-104820","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017024104820/ownership.xml","form_type":"4"}},{"id":1457229,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-07-09T21:30:03.000Z","date":"2024-07-05","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":16.33,"value":130640.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on January 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.97 to $16.77. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":123942,"source":{"system":"sec-edgar","filing":"0000950170-24-082485","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017024082485/ownership.xml","form_type":"4"}},{"id":1461977,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-07-02T23:30:03.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":2360,"price":9,"value":21240.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, the shares were purchased based on 85% of the closing price of the Issuer's common stock on January 2, 2024."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2021 Employee Stock Purchase Plan (the \"ESPP\"), for the purchase period of January 1, 2024 through June 30, 2024. This transaction is also exempt under Rule 16b-3(c)."}],"balance_after":131942,"source":{"system":"sec-edgar","filing":"0000950170-24-080961","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017024080961/ownership.xml","form_type":"4"}},{"id":1522932,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-08T23:30:09.000Z","date":"2024-05-07","kind":"exercise","planned":true,"acquired":false,"shares":5606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares vested on July 4, 2020, and the remaining shares vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":132987,"derivative":{"exercise_price":4.3,"expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":5606},"source":{"system":"sec-edgar","filing":"0000950170-24-056093","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017024056093/ownership.xml","form_type":"4"}},{"id":1522931,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-08T23:30:09.000Z","date":"2024-05-06","kind":"exercise","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares vested on July 4, 2020, and the remaining shares vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":138593,"derivative":{"exercise_price":4.3,"expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-24-056093","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017024056093/ownership.xml","form_type":"4"}},{"id":1522930,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-05-08T23:30:09.000Z","date":"2024-05-07","kind":"sale","planned":true,"acquired":false,"shares":5606,"price":30.06,"value":168516.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on January 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.15. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":129582,"source":{"system":"sec-edgar","filing":"0000950170-24-056093","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017024056093/ownership.xml","form_type":"4"}},{"id":1522929,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-05-08T23:30:09.000Z","date":"2024-05-07","kind":"exercise","planned":true,"acquired":true,"shares":5606,"price":4.3,"value":24105.8,"ownership":{"direct":true},"balance_after":135188,"source":{"system":"sec-edgar","filing":"0000950170-24-056093","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017024056093/ownership.xml","form_type":"4"}},{"id":1522928,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-05-08T23:30:09.000Z","date":"2024-05-06","kind":"sale","planned":true,"acquired":false,"shares":20277,"price":28.54,"value":578705.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on January 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.35 to $28.84. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":129582,"source":{"system":"sec-edgar","filing":"0000950170-24-056093","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017024056093/ownership.xml","form_type":"4"}},{"id":1522927,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-05-08T23:30:09.000Z","date":"2024-05-06","kind":"sale","planned":true,"acquired":false,"shares":37723,"price":27.82,"value":1049453.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on January 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.35 to $28.34. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":149859,"source":{"system":"sec-edgar","filing":"0000950170-24-056093","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017024056093/ownership.xml","form_type":"4"}},{"id":1522926,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-05-08T23:30:09.000Z","date":"2024-05-06","kind":"exercise","planned":true,"acquired":true,"shares":50000,"price":4.3,"value":215000.0,"ownership":{"direct":true},"balance_after":187582,"source":{"system":"sec-edgar","filing":"0000950170-24-056093","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017024056093/ownership.xml","form_type":"4"}},{"id":1621640,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-23T22:00:11.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date."}],"balance_after":100000,"derivative":{"exercise_price":17.54,"expiration_date":"2034-02-22","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000950170-24-019456","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017024019456/ownership.xml","form_type":"4"}},{"id":1621639,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-23T22:00:11.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares underlying the restricted stock unit vest on an annual basis over four years."}],"balance_after":137582,"source":{"system":"sec-edgar","filing":"0000950170-24-019456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017024019456/ownership.xml","form_type":"4"}},{"id":1700564,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-12-22T22:30:05.000Z","date":"2023-12-21","kind":"sale","planned":false,"acquired":false,"shares":1145,"price":8.5,"value":9732.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":87582,"source":{"system":"sec-edgar","filing":"0000950170-23-072753","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017023072753/ownership.xml","form_type":"4"}},{"id":1703097,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-12-20T23:00:14.000Z","date":"2023-12-18","kind":"sale","planned":false,"acquired":false,"shares":238,"price":8.22,"value":1956.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":88727,"source":{"system":"sec-edgar","filing":"0000950170-23-071988","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017023071988/ownership.xml","form_type":"4"}},{"id":1711993,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-12-14T01:00:05.000Z","date":"2023-12-12","kind":"sale","planned":false,"acquired":false,"shares":1068,"price":7.81,"value":8341.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":88965,"source":{"system":"sec-edgar","filing":"0000950170-23-070142","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017023070142/ownership.xml","form_type":"4"}},{"id":1847403,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-06-21T20:17:45.000Z","date":"2023-06-20","kind":"sale","planned":false,"acquired":false,"shares":238,"price":12.94,"value":3079.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":90033,"source":{"system":"sec-edgar","filing":"0000950170-23-029160","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017023029160/ownership.xml","form_type":"4"}},{"id":1855421,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-06-14T20:35:03.000Z","date":"2023-06-12","kind":"sale","planned":false,"acquired":false,"shares":176,"price":13.11,"value":2307.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":90271,"source":{"system":"sec-edgar","filing":"0000950170-23-027984","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017023027984/ownership.xml","form_type":"4"}},{"id":1861673,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T21:10:58.000Z","date":"2023-06-07","kind":"exercise","planned":true,"acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares vested on July 4, 2020, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":188593,"derivative":{"exercise_price":4.3,"expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0000950170-23-027063","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017023027063/ownership.xml","form_type":"4"}},{"id":1861672,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T21:10:58.000Z","date":"2023-06-06","kind":"exercise","planned":true,"acquired":false,"shares":11900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares vested on July 4, 2020, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":188693,"derivative":{"exercise_price":4.3,"expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":11900},"source":{"system":"sec-edgar","filing":"0000950170-23-027063","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017023027063/ownership.xml","form_type":"4"}},{"id":1861671,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-06-08T21:10:58.000Z","date":"2023-06-07","kind":"sale","planned":true,"acquired":false,"shares":100,"price":12.4,"value":1240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on April 29, 2021, as amended on June 24, 2022."}],"balance_after":90447,"source":{"system":"sec-edgar","filing":"0000950170-23-027063","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017023027063/ownership.xml","form_type":"4"}},{"id":1861670,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-06-08T21:10:58.000Z","date":"2023-06-07","kind":"exercise","planned":true,"acquired":true,"shares":100,"price":4.3,"value":430.0,"ownership":{"direct":true},"balance_after":90547,"source":{"system":"sec-edgar","filing":"0000950170-23-027063","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017023027063/ownership.xml","form_type":"4"}},{"id":1861669,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-06-08T21:10:58.000Z","date":"2023-06-06","kind":"sale","planned":true,"acquired":false,"shares":11900,"price":12.31,"value":146489.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on April 29, 2021, as amended on June 24, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.30 to $12.35. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":90447,"source":{"system":"sec-edgar","filing":"0000950170-23-027063","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017023027063/ownership.xml","form_type":"4"}},{"id":1861668,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-06-08T21:10:58.000Z","date":"2023-06-06","kind":"exercise","planned":true,"acquired":true,"shares":11900,"price":4.3,"value":51170.0,"ownership":{"direct":true},"balance_after":102347,"source":{"system":"sec-edgar","filing":"0000950170-23-027063","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017023027063/ownership.xml","form_type":"4"}},{"id":1883962,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-05-19T20:51:35.000Z","date":"2023-05-18","kind":"sale","planned":false,"acquired":false,"shares":239,"price":8.76,"value":2093.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":90447,"source":{"system":"sec-edgar","filing":"0000899243-23-013364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924323013364/doc4.xml","form_type":"4"}},{"id":1890916,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-05-16T21:36:55.000Z","date":"2023-05-12","kind":"sale","planned":false,"acquired":false,"shares":193,"price":8.78,"value":1694.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":90686,"source":{"system":"sec-edgar","filing":"0000950170-23-022557","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017023022557/ownership.xml","form_type":"4"}},{"id":1916207,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-04-20T20:32:12.000Z","date":"2023-04-18","kind":"sale","planned":false,"acquired":false,"shares":238,"price":10.71,"value":2548.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":90879,"source":{"system":"sec-edgar","filing":"0000950170-23-013701","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017023013701/ownership.xml","form_type":"4"}},{"id":1919345,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-04-14T22:23:27.000Z","date":"2023-04-12","kind":"sale","planned":false,"acquired":false,"shares":176,"price":10.22,"value":1798.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":91117,"source":{"system":"sec-edgar","filing":"0000899243-23-011292","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924323011292/doc4.xml","form_type":"4"}},{"id":1937604,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-03-27T20:05:24.000Z","date":"2023-03-20","kind":"sale","planned":false,"acquired":false,"shares":238,"price":11.32,"value":2694.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":91293,"source":{"system":"sec-edgar","filing":"0000899243-23-009716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924323009716/doc4.xml","form_type":"4"}},{"id":2002745,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-21T23:52:34.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":77000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date."}],"balance_after":77000,"derivative":{"exercise_price":11.34,"expiration_date":"2033-02-16","underlying":"Common Stock","underlying_shares":77000},"source":{"system":"sec-edgar","filing":"0000899243-23-005729","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924323005729/doc4.xml","form_type":"4"}},{"id":2002744,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-02-21T23:52:34.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":38500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares underlying the restricted stock unit vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date."}],"balance_after":91531,"source":{"system":"sec-edgar","filing":"0000899243-23-005729","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924323005729/doc4.xml","form_type":"4"}},{"id":2102140,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-29T21:05:14.000Z","date":"2022-11-25","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares vested on July 4, 2020, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":200593,"derivative":{"exercise_price":4.3,"expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000899243-22-037126","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924322037126/doc4.xml","form_type":"4"}},{"id":2102139,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-11-29T21:05:14.000Z","date":"2022-11-25","kind":"sale","acquired":false,"shares":4000,"price":13.3,"value":53200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on April 29, 2021, as amended on June 24, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.96 to $13.48. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":53031,"source":{"system":"sec-edgar","filing":"0000899243-22-037126","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924322037126/doc4.xml","form_type":"4"}},{"id":2102138,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-11-29T21:05:14.000Z","date":"2022-11-25","kind":"exercise","acquired":true,"shares":4000,"price":4.3,"value":17200.0,"ownership":{"direct":true},"balance_after":57031,"source":{"system":"sec-edgar","filing":"0000899243-22-037126","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924322037126/doc4.xml","form_type":"4"}},{"id":2149250,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-29T20:05:16.000Z","date":"2022-09-27","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares vested on July 4, 2020, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":204593,"derivative":{"exercise_price":4.3,"expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000899243-22-032236","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924322032236/doc4.xml","form_type":"4"}},{"id":2149249,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-09-29T20:05:16.000Z","date":"2022-09-27","kind":"sale","acquired":false,"shares":4000,"price":12.4,"value":49600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on April 29, 2021, as amended on June 24, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.30 to $12.56. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":53031,"source":{"system":"sec-edgar","filing":"0000899243-22-032236","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924322032236/doc4.xml","form_type":"4"}},{"id":2149248,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-09-29T20:05:16.000Z","date":"2022-09-27","kind":"exercise","acquired":true,"shares":4000,"price":4.3,"value":17200.0,"ownership":{"direct":true},"balance_after":57031,"source":{"system":"sec-edgar","filing":"0000899243-22-032236","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924322032236/doc4.xml","form_type":"4"}},{"id":2190374,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-09T21:36:04.000Z","date":"2022-08-08","kind":"exercise","acquired":false,"shares":1385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares vested on July 4, 2020, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":208593,"derivative":{"exercise_price":4.3,"expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":1385},"source":{"system":"sec-edgar","filing":"0000899243-22-028132","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924322028132/doc4.xml","form_type":"4"}},{"id":2190373,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2022-08-09T21:36:04.000Z","date":"2022-08-08","kind":"sale","acquired":false,"shares":1385,"price":15.01,"value":20788.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on April 29, 2021, as amended on June 24, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.04. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":53031,"source":{"system":"sec-edgar","filing":"0000899243-22-028132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924322028132/doc4.xml","form_type":"4"}},{"id":2190372,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2022-08-09T21:36:04.000Z","date":"2022-08-08","kind":"exercise","acquired":true,"shares":1385,"price":4.3,"value":5955.5,"ownership":{"direct":true},"balance_after":54416,"source":{"system":"sec-edgar","filing":"0000899243-22-028132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924322028132/doc4.xml","form_type":"4"}},{"id":2201677,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-26T21:44:12.000Z","date":"2022-07-25","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares vested on July 4, 2020, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":209978,"derivative":{"exercise_price":4.3,"expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0000899243-22-026737","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924322026737/doc4.xml","form_type":"4"}},{"id":2201676,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2022-07-26T21:44:12.000Z","date":"2022-07-25","kind":"sale","acquired":false,"shares":8000,"price":14.51,"value":116080.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on April 29, 2021, as amended on June 24, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.14 to $14.76. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":53031,"source":{"system":"sec-edgar","filing":"0000899243-22-026737","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924322026737/doc4.xml","form_type":"4"}},{"id":2201675,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2022-07-26T21:44:12.000Z","date":"2022-07-25","kind":"exercise","acquired":true,"shares":8000,"price":4.3,"value":34400.0,"ownership":{"direct":true},"balance_after":61031,"source":{"system":"sec-edgar","filing":"0000899243-22-026737","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924322026737/doc4.xml","form_type":"4"}},{"id":2213889,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2022-07-05T22:10:49.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":1620,"price":10.9,"value":17658.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2021 Employee Stock Purchase Plan (the \"ESPP\"), for the purchase period of January 1, 2022 through June 30, 2022. This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, the shares were purchased based on 85% of the closing price of the Issuer's common stock on June 30, 2022."}],"balance_after":53031,"source":{"system":"sec-edgar","filing":"0000899243-22-025082","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924322025082/doc4.xml","form_type":"4"}},{"id":2393796,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-15T21:55:52.000Z","date":"2022-02-11","kind":"grant","acquired":true,"shares":57000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option vest over four years, with one forty-eighty (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date."}],"balance_after":57000,"derivative":{"exercise_price":13.6,"expiration_date":"2032-02-10","underlying":"Common Stock","underlying_shares":57000},"source":{"system":"sec-edgar","filing":"0000899243-22-006427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924322006427/doc4.xml","form_type":"4"}},{"id":2393795,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2022-02-15T21:55:52.000Z","date":"2022-02-11","kind":"grant","acquired":true,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares underlying the restricted stock unit vest over four years, with one forty-eighty (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date."}],"balance_after":51411,"source":{"system":"sec-edgar","filing":"0000899243-22-006427","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924322006427/doc4.xml","form_type":"4"}},{"id":2537853,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-20T20:30:16.000Z","date":"2021-10-18","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares vested on July 4, 2020, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":217978,"derivative":{"exercise_price":4.3,"expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000899243-21-040764","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924321040764/doc4.xml","form_type":"4"}},{"id":2537852,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-10-20T20:30:16.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":400,"price":23.61,"value":9444.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on April 29, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.26 to $23.96. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":22911,"source":{"system":"sec-edgar","filing":"0000899243-21-040764","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924321040764/doc4.xml","form_type":"4"}},{"id":2537851,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-10-20T20:30:16.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":204,"price":22.4,"value":4569.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on April 29, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.03 to $22.73. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":23311,"source":{"system":"sec-edgar","filing":"0000899243-21-040764","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924321040764/doc4.xml","form_type":"4"}},{"id":2537850,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-10-20T20:30:16.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":3396,"price":21.1,"value":71655.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on April 29, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.00 to $21.95. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":23515,"source":{"system":"sec-edgar","filing":"0000899243-21-040764","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924321040764/doc4.xml","form_type":"4"}},{"id":2537849,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-10-20T20:30:16.000Z","date":"2021-10-18","kind":"exercise","acquired":true,"shares":4000,"price":4.3,"value":17200.0,"ownership":{"direct":true},"balance_after":26911,"source":{"system":"sec-edgar","filing":"0000899243-21-040764","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924321040764/doc4.xml","form_type":"4"}},{"id":2562599,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-21T20:30:31.000Z","date":"2021-09-20","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares vested on July 4, 2020, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":221978,"derivative":{"exercise_price":4.3,"expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000899243-21-036782","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924321036782/doc4.xml","form_type":"4"}},{"id":2562598,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-09-21T20:30:31.000Z","date":"2021-09-20","kind":"sale","acquired":false,"shares":800,"price":25.2,"value":20160.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on April 29, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.95 to $25.48. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":22911,"source":{"system":"sec-edgar","filing":"0000899243-21-036782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924321036782/doc4.xml","form_type":"4"}},{"id":2562597,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-09-21T20:30:31.000Z","date":"2021-09-20","kind":"sale","acquired":false,"shares":3200,"price":24.34,"value":77888.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on April 29, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.92 to $24.89. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":23711,"source":{"system":"sec-edgar","filing":"0000899243-21-036782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924321036782/doc4.xml","form_type":"4"}},{"id":2562596,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-09-21T20:30:31.000Z","date":"2021-09-20","kind":"exercise","acquired":true,"shares":4000,"price":4.3,"value":17200.0,"ownership":{"direct":true},"balance_after":26911,"source":{"system":"sec-edgar","filing":"0000899243-21-036782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924321036782/doc4.xml","form_type":"4"}},{"id":2589202,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-26T23:15:16.000Z","date":"2021-08-18","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares vested on July 4, 2020, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":225978,"derivative":{"exercise_price":4.3,"expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000899243-21-034312","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924321034312/doc4a.xml","form_type":"4/A","original_submission_date":"2021-08-24"}},{"id":2589201,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-08-26T23:15:16.000Z","date":"2021-08-18","kind":"sale","acquired":false,"shares":1137,"price":28.07,"value":31915.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on April 29, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $27.92 to $28.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":22911,"source":{"system":"sec-edgar","filing":"0000899243-21-034312","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924321034312/doc4a.xml","form_type":"4/A","original_submission_date":"2021-08-24"}},{"id":2589200,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-08-26T23:15:16.000Z","date":"2021-08-18","kind":"sale","acquired":false,"shares":2863,"price":27.5,"value":78732.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on April 29, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $26.91 to $27.89. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":24048,"source":{"system":"sec-edgar","filing":"0000899243-21-034312","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924321034312/doc4a.xml","form_type":"4/A","original_submission_date":"2021-08-24"}},{"id":2589199,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-08-26T23:15:16.000Z","date":"2021-08-18","kind":"exercise","acquired":true,"shares":4000,"price":4.3,"value":17200.0,"ownership":{"direct":true},"balance_after":26911,"source":{"system":"sec-edgar","filing":"0000899243-21-034312","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924321034312/doc4a.xml","form_type":"4/A","original_submission_date":"2021-08-24"}},{"id":2591830,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-24T20:06:10.000Z","date":"2021-08-18","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares vested on July 4, 2020, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":225978,"derivative":{"exercise_price":4.3,"expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000899243-21-034025","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924321034025/doc4.xml","form_type":"4"}},{"id":2591829,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-08-24T20:06:10.000Z","date":"2021-08-18","kind":"sale","acquired":false,"shares":1137,"price":28.07,"value":31915.59,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $27.92 to $28.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":22911,"source":{"system":"sec-edgar","filing":"0000899243-21-034025","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924321034025/doc4.xml","form_type":"4"}},{"id":2591828,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":23207,"kind":"person","name":"Michaelson Jennifer","position":1,"cik":"0001838061","reported_name":"Michaelson Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-08-24T20:06:10.000Z","date":"2021-08-18","kind":"sale","acquired":false,"shares":2863,"price":27.5,"value":78732.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $26.91 to $27.89. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":24048,"source":{"system":"sec-edgar","filing":"0000899243-21-034025","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924321034025/doc4.xml","form_type":"4"}}],"next_cursor":"2021-08-24T20:06:10.000000Z,2591828"}